{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:11:41Z","timestamp":1782457901855,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Indonesia Science Fund-Indonesia Endowment Fund for Education (Dana Ilmu Pengetahuan Indonesia\/DIPI- Lembaga Pengelola Dana Pendidikan\/LPDP), Indonesia","award":["MR\/P015816\/1"],"award-info":[{"award-number":["MR\/P015816\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rapid emergence of <jats:italic>Plasmodium<\/jats:italic> resistance to anti-malarial drug mainstays has driven a continual effort to discover novel drugs that target different biochemical pathway (s) during infection. Plasma membrane Calcium\u2009+\u20092 ATPase (PMCA4), a novel plasma membrane protein that regulates Calcium levels in various cells, namely red blood cell (RBC), endothelial cell and platelets, represents a new biochemical pathway that may interfere with susceptibility to malaria and\/or severe malaria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study identified several pharmacological inhibitors of PMCA4, namely ATA and Resveratrol, and tested for their anti-malarial activities in vitro and in vivo using the <jats:italic>Plasmodium falciparum<\/jats:italic> 3D7 strain, the <jats:italic>Plasmodium berghei<\/jats:italic> ANKA strain, and <jats:italic>Plasmodium yoelii<\/jats:italic> 17XL strain as model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In vitro propagation of <jats:italic>P. falciparum<\/jats:italic> 3D7 strain in the presence of a wide concentration range of the inhibitors revealed that the parasite growth was inhibited in a dose-dependent manner, with IC<jats:sub>50<\/jats:sub>s at 634 and 0.231\u00a0\u00b5M, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results confirmed that both compounds exhibit moderate to potent anti-malarial activities with the strongest parasite growth inhibition shown by resveratrol at 0.231\u00a0\u00b5M. In vivo models using <jats:italic>P. berghei<\/jats:italic> ANKA for experimental cerebral malaria and <jats:italic>P. yoelii<\/jats:italic> 17XL for the effect on parasite growth, showed that the highest dose of ATA, 30\u00a0mg\/kg BW, increased survival of the mice. Likewise, resveratrol inhibited the parasite growth following 4\u00a0days intraperitoneal injection at the dose of 100\u00a0mg\/kg BW.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The findings indicate that the PMCA4 of the human host may be a potential target for novel anti-malarials, either as single drug or in combination with the currently available effective anti-malarials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-022-04228-0","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T07:07:05Z","timestamp":1656486425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment with specific and pan-plasma membrane calcium ATPase (PMCA) inhibitors reduces malaria parasite growth in vitro and in vivo"],"prefix":"10.1186","volume":"21","author":[{"given":"Puji B. S.","family":"Asih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine E.","family":"Siregar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahana K.","family":"Dewayanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normalita E.","family":"Pravitasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail E.","family":"Rozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andita F. M.","family":"Rizki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifqi","family":"Risandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Couper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delvac","family":"Oceandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Din","family":"Syafruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"4228_CR1","volume-title":"World Malaria Report 2020: 20 years of global progress and challenges","author":"WHO","year":"2020","unstructured":"WHO. World Malaria Report 2020: 20 years of global progress and challenges. Geneva: World Health Organization; 2020."},{"key":"4228_CR2","unstructured":"Ministry of Health, Republic of Indonesia. Informasi Malaria Indonesia. 2022. https:\/\/www.malaria.id\/"},{"key":"4228_CR3","volume-title":"Global report on antimalarial drug efficacy and drug resistance","author":"WHO","year":"2010","unstructured":"WHO. Global report on antimalarial drug efficacy and drug resistance. Geneva: World Health Organization; 2010."},{"key":"4228_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11334","volume":"489","author":"C Timmann","year":"2012","unstructured":"Timmann C, Thye T, Vens M, Evans J, May J, Ehmen C, et al. Genome-wide association study indicates two novel resistance loci for severe malaria. Nature. 2012;489:443\u20136.","journal-title":"Nature"},{"key":"4228_CR5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1152\/physrev.00028.2016","volume":"97","author":"N Stafford","year":"2017","unstructured":"Stafford N, Wilson C, Oceandy D, Neyses L, Cartwright EJ. The plasma membrane calcium ATPases and their role as major new players in human disease. Physiol Rev. 2017;97:1089\u2013125.","journal-title":"Physiol Rev"},{"key":"4228_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-3-319-24780-9_5","volume-title":"Regulation of Ca2+-ATPases, V-ATPases and F-ATPases","author":"EE Strehler","year":"2016","unstructured":"Strehler EE. The ATP2B plasma membrane Ca2+ ATPase family: regulation in response to changing demands of cellular calcium transport. In: Chakraborti S, Dhalla NS, editors. Regulation of Ca2+-ATPases, V-ATPases and F-ATPases. Berlin: Springer; 2016. p. 63\u201380."},{"key":"4228_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.2001.81.1.21","volume":"81","author":"EE Strehler","year":"2001","unstructured":"Strehler EE, Zacharias DA. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev. 2001;81:21\u201350.","journal-title":"Physiol Rev"},{"key":"4228_CR8","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1172\/JCI94378","volume":"127","author":"S Lessard","year":"2017","unstructured":"Lessard S, Gatof ES, Beaudoin M, Schupp PG, Sher F, Ali A, et al. An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility. J Clin Invest. 2017;127:3065\u201374.","journal-title":"J Clin Invest"},{"key":"4228_CR9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.bbamcr.2010.12.007","volume":"1813","author":"D Oceandy","year":"2011","unstructured":"Oceandy D, Mohammed TMA, Cartwright EJ, Neyses L. Local signals with global impacts and clinical implications: lessons from the plasma membrane calcium pump (PMCA4). Biochim Biophys Acta. 2011;1813:974\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"4228_CR10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1152\/physrev.00028.2016","volume":"97","author":"N Stafford","year":"2017","unstructured":"Stafford N, Wilson C, Ocenady D, Neyses L, Cartwright EJ. The plasma membrane Calcium ATPases and their role as major new players in human disease. Physiol Rev. 2017;97:1089\u2013125.","journal-title":"Physiol Rev"},{"key":"4228_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.1166296","volume":"323","author":"BJ McMorran","year":"2009","unstructured":"McMorran BJ, Marshall VM, de Graaf C, Drysdale KE, Shabbar M, Smyth GK, et al. Platelets kill intra erythrocytic malarial parasites and mediate survival to infection. Science. 2009;323:797\u2013800.","journal-title":"Science"},{"key":"4228_CR12","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1038\/s41467-019-13480-z","volume":"10","author":"MGE Network","year":"2019","unstructured":"Network MGE. Insight into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania. Nat Commun. 2019;10:5732.","journal-title":"Nat Commun"},{"key":"4228_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yjmcc.2013.07.007","volume":"63","author":"TMA Mohammed","year":"2013","unstructured":"Mohammed TMA, Abou-Leisa R, Baudoin F, Stafford N, Neyses L, Cartwright EJ, et al. Development and characterization of a novel fluorescent indicator protein PMCA4-GcaMP2 in cardiomyocytes. J Mol Cell Cardiol. 2013;63:57\u20138.","journal-title":"J Mol Cell Cardiol"},{"key":"4228_CR14","first-page":"217","volume":"16","author":"TMA Mohamed","year":"2013","unstructured":"Mohamed TMA, Zakeri SA, Baudoin F, Wolf M, Oceandy D, Cartwright EJ, et al. Optimisation and validation of a high throughput screening compatible assay to identify inhibitors of the plasma membrane calcium ATPase pump\u2013a novel therapeutic target for contraception and malaria. J Pharm Sci. 2013;16:217\u201330.","journal-title":"J Pharm Sci"},{"key":"4228_CR15","first-page":"253","volume":"7","author":"JA Peterson","year":"2016","unstructured":"Peterson JA, Oblad RV, Mecham JC, Kenealey JD. Resveratrol inhibits plasma membrane Ca2+-ATPase inducing an increase in cytoplasmic calcium. Biochem Biophys Rep. 2016;7:253\u20138.","journal-title":"Biochem Biophys Rep"},{"key":"4228_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.yjmcc.2017.07.001","volume":"109","author":"S Kurusamy","year":"2017","unstructured":"Kurusamy S, L\u00f3pez-Maderuelo D, Little R, Cadagan D, Savage AM, Ihugba JC, et al. Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion. J Mol Cell Cardiol. 2017;109:38\u201347.","journal-title":"J Mol Cell Cardiol"},{"key":"4228_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673\u20135.","journal-title":"Science"},{"key":"4228_CR18","unstructured":"Moll K. Freezing and thawing asexual Plasmodium spp. In: Moll K, Kaneko A, Scherf A, Wahlgren M, Eds. 6th Edn. Methods in Malaria Research. Malaria Research and Reference Reagent Resource Centre (MR4), 2013; 17\u201318."},{"key":"4228_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S2352-3026(18)30107-8","volume":"5","author":"CM Ndila","year":"2018","unstructured":"Ndila CM, Uyoga S, Macharia AW, Nyutu G, Peshu N, Ojal J, et al. Human candidate gene polymorphism and risk of severe malaria in children in Kilifi, Kenya: a case-control association study. Lancet Haematol. 2018;5:333\u201345.","journal-title":"Lancet Haematol"},{"key":"4228_CR20","doi-asserted-by":"publisher","first-page":"33742","DOI":"10.1074\/jbc.M404628200","volume":"279","author":"GW Okunade","year":"2004","unstructured":"Okunade GW, Miller ML, Pyne GJ, Sutliff RL, O\u2019Connor KT, Neumann JC, et al. Targeted ablation of plasma membrane Ca2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J Biol Chem. 2004;279:33742\u201350.","journal-title":"J Biol Chem"},{"key":"4228_CR21","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.bbrc.2004.07.156","volume":"322","author":"V Prasad","year":"2004","unstructured":"Prasad V, Okunade GW, Miller ML, Shull GE. Phenotypes of SERCA and PMCA knockout mice. Biochem Biophys Res Commun. 2004;322:1192\u2013203.","journal-title":"Biochem Biophys Res Commun"},{"key":"4228_CR22","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/infdis\/jit070","volume":"207","author":"G Bedu-Addo","year":"2013","unstructured":"Bedu-Addo G, Meese S, Mockenhaup FP. An ATP2B4 polymorphism protects against malaria in pregnancy. J Infect Dis. 2013;207:1600\u20133.","journal-title":"J Infect Dis"},{"key":"4228_CR23","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1182\/blood-2004-12-4948","volume":"105","author":"T Tiffert","year":"2005","unstructured":"Tiffert T, Lew VL, Ginsburg H, Krugliak M, Croisille L, Mohandas N. The hydration state of human red blood cells and their susceptibility to invasion by Plasmodium falciparum. Blood. 2005;105:4853\u2013948.","journal-title":"Blood"},{"key":"4228_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12936-021-03832-w","volume":"20","author":"A Villegas-Mendez","year":"2021","unstructured":"Villegas-Mendez A, Stafford N, Haley MJ, Pravitasari NE, Baudoin F, Ali A, et al. The plasma membrane calcium ATPase 4 does not influence parasite levels but partially promotes experimental cerebral malaria during murine blood stage malaria. Malar J. 2021;20:297.","journal-title":"Malar J"},{"key":"4228_CR25","doi-asserted-by":"publisher","first-page":"11074","DOI":"10.1038\/ncomms11074","volume":"7","author":"TMA Mohammed","year":"2016","unstructured":"Mohammed TMA, Abou-Leisa R, Baudoin F, Stafford N, Neyses L, Cartwright EJ, et al. The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy. Nature Comm. 2016;7:11074.","journal-title":"Nature Comm"},{"key":"4228_CR26","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1093\/nar\/4.9.3055","volume":"4","author":"RB Hallick","year":"1977","unstructured":"Hallick RB, Chelm BK, Gray PW, Orozco EM Jr. Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation. Nucleic Acids Res. 1977;4:3055\u201364.","journal-title":"Nucleic Acids Res"},{"key":"4228_CR27","first-page":"291","volume":"36","author":"A Posner","year":"1995","unstructured":"Posner A, Raser KJ, Hajimohammadreza I, Yuen PW, Wang KK. Aurintricarboxylic acid is an inhibitor of mu- and m-calpain. Biochem Mol Biol Int. 1995;36:291\u20139.","journal-title":"Biochem Mol Biol Int"},{"issue":"4","key":"4228_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008350","volume":"2009","author":"AM Hashem","year":"2009","unstructured":"Hashem AM, Flaman AS, Farnsworth A, Brown EG, Domseelar GV, He R, Li X. Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. PLoS ONE. 2009;2009(4): e8350.","journal-title":"PLoS ONE"},{"key":"4228_CR29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.2203\/dose-response.09-015.Mukherjee","volume":"8","author":"S Mukherjee","year":"2010","unstructured":"Mukherjee S, Dudley J, Das DK. Dose-dependency of Resveratrol in providing health benefits. Dose-Response. 2010;8:478\u2013500.","journal-title":"Dose-Response"},{"key":"4228_CR30","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s10616-015-9898-1","volume":"68","author":"P Santofimia-Castano","year":"2016","unstructured":"Santofimia-Castano P, Salido GM, Gonzalez A. Interferences of Resveratrol with fura-2-derived fluorescence in intracellular free-Ca2+ concentration determinations. Cytotechnology. 2016;68:1369\u201380.","journal-title":"Cytotechnology"},{"key":"4228_CR31","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.bbadis.2014.10.005","volume":"852","author":"SS Kulkarni","year":"2015","unstructured":"Kulkarni SS, Cant\u00f3 C. The molecular targets of resveratrol. Biochim Biophys Acta. 2015;852:1114\u201323.","journal-title":"Biochim Biophys Acta"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04228-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04228-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04228-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T07:09:53Z","timestamp":1656486593000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04228-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4228"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04228-0","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}